PharmTech Europe News

Oct 15, 2018
By Pharmaceutical Technology Editors
Clovis Oncology and Lonza celebrated the grand opening of a dedicated production train at Lonza’s Visp, Switzerland site for manufacturing Rubraca (rucaparib).
Oct 12, 2018
By Pharmaceutical Technology Editors
Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab).
Oct 11, 2018
By Pharmaceutical Technology Editors
Roche has acquired Tusk Therapeutics in a deal worth up to EUR 659 million (US$762 million).
Oct 11, 2018
Biotechnology developers should be aware of subtle differences between the way that European and United States patent authorities approach monoclonal antibodies.
Oct 10, 2018
By Pharmaceutical Technology Editors
The company’s three acquisitions over the last 12 months have increased its global presence, expanding its European footprint and bringing new localized services in Asia-Pacific and the west coast of the United States.
Oct 10, 2018
By Pharmaceutical Technology Editors
A stick-pack laminate packaging film from Amcor uses Pylote’s antimicrobial packaging technology to eliminate the need for preservatives in the liquid pharmaceutical contents.
Oct 09, 2018
By Pharmaceutical Technology Editors
Bormioli Pharma, a provider of integrated glass and plastic containers, closures, and accessories for packaging, will showcase products at CPhI Worldwide 2018 at booth 4C20, from Oct. 9–11, 2018.
Oct 09, 2018
By Pharmaceutical Technology Editors
The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.
Oct 09, 2018
By Pharmaceutical Technology Editors
At CPhI Worldwide 2018, Tom Wilson, vice president of Contract Manufacturing Operations for Pfizer Global Supply and Pfizer CentreOne Contract Manufacturing, will discuss best practices for meeting manufacturing challenges of compliance as requirements shift.
Oct 05, 2018
By Pharmaceutical Technology Editors
Luxembourg-based pharmaceutical group, C2 Pharma (formerly known as Centroflora CMS) successfully validated the manufacturing process for two APIs—digoxin and digoxin micron.
native1_300x100
lorem ipsum